1 0

    FDA FAERS Reports on ELEVIDYS (SRP-9001) from 01/01/24 to 01/31/25

    FDA FAERS Reports on ELEVIDYS (SRP-9001) from 01/01/24 to 01/31/25

    $89.00 USD
    $89.00 USD
    Sale Sold out
    Original Request: FDA FAERS reports on the drug ELEVIDYS (delandistrogene moxeparvovec; also known as SRP-9001), from 1/1/24 to 1/31/25 (or the latest date available). Please look for events under both the brand and generic names. Where possible, please include full narrative of events, and email the results in a PDF or Excel file.
    Tags: Pharma, FAERS, 2025
    • Status: Pending Fast-Track Request
    • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

    NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

    View full details